TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.
Name / Ticker | Price | Zen Rating |
---|---|---|
$8.18 | A | |
$41.59 | A | |
$23.53 | A |